Today's Date
GLA-AF plus antigen-specific immunotherapy in individuals with seasonal allergic rhinitis
(
GLASS
)
ITN Protocol #:
ITN072AD
Branded Name:
GLASS
Treatment Protocol #:
Therapeutic Area:
Allergy & Asthma
Current Status:
Withdrawn
Summary:
GLA plus antigen-specific immunotherapy for induction of tolerance in individuals with grass allergy
Clinical Operations Manager
ITN Clinical Trial Physician
Study Personnel:
